Results 301 to 310 of about 162,800 (333)
Consumer wearable devices for evaluation of heart rate control using digoxin versus beta-blockers: the RATE-AF randomized trial. [PDF]
Nat MedGill SK +19 more
europepmc +1 more source
Obstetrical & Gynecological Survey, 1981 DRUGS that competitively antagonize the effects of catecholamines at beta-adrenoreceptors have been in clinical use since the mid-1960s.
openaire +7 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
2015
Infantile hemangiomas (IHs) are the most common tumors in infancy. Their typical natural history is characterized by an early rapid growth in the first months of life and by a slow spontaneous involution in the first years of life. Even though spontaneous regression of IHs could suggest therapeutic abstention, systemic treatment is the therapy of ...
C. Gelmetti, R. Cavalli
openaire +5 more sources
Infantile hemangiomas (IHs) are the most common tumors in infancy. Their typical natural history is characterized by an early rapid growth in the first months of life and by a slow spontaneous involution in the first years of life. Even though spontaneous regression of IHs could suggest therapeutic abstention, systemic treatment is the therapy of ...
C. Gelmetti, R. Cavalli
openaire +5 more sources
Beta-blockers for hypertension
2012This review is an update of the Cochrane Review published in 2007, which assessed the role of beta-blockade as first-line therapy for hypertension.To quantify the effectiveness and safety of beta-blockers on morbidity and mortality endpoints in adults with hypertension.In December 2011 we searched the Cochrane Central Register of Controlled Trials ...
Charles Shey, Wiysonge +5 more
openaire +3 more sources
European Journal of Clinical Pharmacology, 1982
In a randomized, blind crossover study in 14 hypertensive patients with asthma, involving placebo and chronically administered (3 weeks) equipotent beta1-blocking doses of atenolol 100 mg once daily and metoprolol 100 mg bid, atenolol and metoprolol produced a similar fall in blood pressure.
D. S. Lawrence +3 more
openaire +3 more sources
In a randomized, blind crossover study in 14 hypertensive patients with asthma, involving placebo and chronically administered (3 weeks) equipotent beta1-blocking doses of atenolol 100 mg once daily and metoprolol 100 mg bid, atenolol and metoprolol produced a similar fall in blood pressure.
D. S. Lawrence +3 more
openaire +3 more sources
The vasodilatory beta-blockers
Current Hypertension Reports, 2007Although well established in treating hypertension and cardiovascular (CV) disease, clinical trial data suggest that beta-blockers (eg, atenolol) may be less effective than other antihypertensive classes in reducing stroke and CV mortality despite similar blood pressure (BP) reductions.
John R. Cockcroft, Michala E. Pedersen
openaire +2 more sources
Psychiatric Services, 1984
Beta-adrenergic receptor blocking drugs, although not approved by the Food and Drug Administration for treatment of psychiatric disorders, have been used with increasing success in psychiatry. Many beta-blockers are now available, but only those that have high lipid solubility and thus readily penetrate the brain, such as propranolol and oxprenolol ...
Burton J. Goldstein, Dominguez Ra
openaire +3 more sources
Beta-adrenergic receptor blocking drugs, although not approved by the Food and Drug Administration for treatment of psychiatric disorders, have been used with increasing success in psychiatry. Many beta-blockers are now available, but only those that have high lipid solubility and thus readily penetrate the brain, such as propranolol and oxprenolol ...
Burton J. Goldstein, Dominguez Ra
openaire +3 more sources
Beta-blockers in patients with cirrhosis and ascites: type of beta-blocker matters
Gut, 2016Letter to the Editor: We read with great interest the article by Leithead et al ,1 which showed that non-selective beta-blocker (NSBB) therapy was found to be beneficial for patients with ascites, and associated with reduced waitlist deaths even in those with refractory ascites. The study by Serste et al 2 was the first to suggest that NSBB therapy is
Thomas R. McCarty +2 more
openaire +3 more sources
The American Journal of Cardiology, 1983
Beta-adrenoceptor antagonists are effective in the management of patients with mild-to-moderate hypertension. Noncardioselective agents, cardioselective agents and beta blockers with intrinsic sympathomimetic activity (ISA) are equally effective, provided they are used in equipotent doses.
openaire +3 more sources
Beta-adrenoceptor antagonists are effective in the management of patients with mild-to-moderate hypertension. Noncardioselective agents, cardioselective agents and beta blockers with intrinsic sympathomimetic activity (ISA) are equally effective, provided they are used in equipotent doses.
openaire +3 more sources